You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 20, 2025

Vanda Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Vanda Pharms Inc
International Patents:375
US Patents:46
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Vanda Pharms Inc

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-003 May 6, 2009 RX Yes No 8,586,610 ⤷  Subscribe ⤷  Subscribe
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-004 May 6, 2009 RX Yes No 9,074,255 ⤷  Subscribe ⤷  Subscribe
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-004 May 6, 2009 RX Yes No 9,138,432 ⤷  Subscribe ⤷  Subscribe
Vanda Pharms Inc PONVORY ponesimod TABLET;ORAL 213498-005 Mar 18, 2021 RX Yes No ⤷  Subscribe ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries

Expired US Patents for Vanda Pharms Inc

ApplicantTradenameGeneric NameDosageNDAApproval DatePatent No.Patent Expiration
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-006 May 6, 2009 RE39198 ⤷  Subscribe
Vanda Pharms Inc PONVORY ponesimod TABLET;ORAL 213498-010 Mar 18, 2021 9,000,018 ⤷  Subscribe
Vanda Pharms Inc PONVORY ponesimod TABLET;ORAL 213498-001 Mar 18, 2021 9,000,018 ⤷  Subscribe
Vanda Pharms Inc PONVORY ponesimod TABLET;ORAL 213498-009 Mar 18, 2021 9,000,018 ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>Patent No.>Patent Expiration
Showing 1 to 4 of 4 entries
Paragraph IV (Patent) Challenges for VANDA PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 20 mg ➤ Subscribe 2018-01-31
➤ Subscribe Capsules 20 mg ➤ Subscribe 2018-01-31
➤ Subscribe Tablets 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, & 12 mg ➤ Subscribe 2013-05-06

Supplementary Protection Certificates for Vanda Pharms Inc Drugs

Patent NumberSupplementary Protection CertificateSPC CountrySPC ExpirationSPC Description
3256125 2022C/515 Belgium ⤷  Subscribe PRODUCT NAME: PONESIMOD (IUPAC NAAM: (R)-5-(3-CHLORO-4-(2,3-DIHYDROXY-PROPOXY)- BENZ(Z)YLIDEEN)-2-((Z)-PROPYLIMINO)-3-O-TOLYL-THIAZOLIDIN-4-ON); AUTHORISATION NUMBER AND DATE: EU/1/21/1550 20210521
3256125 22C1021 France ⤷  Subscribe PRODUCT NAME: PONESIMOD ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/21/1550 20210521
3256125 C03256125/01 Switzerland ⤷  Subscribe PRODUCT NAME: PONESIMOD; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68114 16.11.2021
3256125 PA2022505,C3256125 Lithuania ⤷  Subscribe PRODUCT NAME: PONEZIMODAS; REGISTRATION NO/DATE: EU/1/21/1550 20210519
>Patent Number>Supplementary Protection Certificate>SPC Country>SPC Expiration>SPC Description
Showing 1 to 4 of 4 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.